Valuation: Dr. Reddy's Laboratories Limited

Market Cap 1,01800Cr 1.06TCr 933.02Cr 882.27Cr 800.24Cr 1.5TCr 1.51TCr 11TCr 4.08TCr 52TCr 3.98TCr 3.9TCr 1,67000Cr P/E 2027 *
27.3x
P/E 2028 * 21.1x
Enterprise Value 99TCr 1.03TCr 904.08Cr 854.91Cr 775.42Cr 1.46TCr 1.46TCr 10TCr 3.95TCr 50TCr 3.86TCr 3.78TCr 1,61800Cr EV / Sales 2027 *
2.8x
EV / Sales 2028 * 2.46x
Free-Float
69.7%
Yield 2027 *
0.62%
Yield 2028 * 0.69%
1 day+2.12%
1 week+0.89%
Current month+3.13%
1 month+2.71%
3 months-18.66%
6 months-7.20%
Current year-10.90%
1 week 12.17
Extreme 12.17
12.67
1 month 11.51
Extreme 11.51
12.72
Current year 11.36
Extreme 11.36
15.67
1 year 11.36
Extreme 11.36
15.67
3 years 11.36
Extreme 11.36
16.89
5 years 9.58
Extreme 9.576
16.89
10 years 5.63
Extreme 5.626
16.89
Manager TitleAgeSince
Chief Executive Officer 59 01/07/2019
Director of Finance/CFO - 01/08/2024
Chief Operating Officer - -
Director TitleAgeSince
Chairman 58 13/05/2014
Chairman 65 02/04/2013
Director/Board Member 65 25/10/2018
Change 5-day change 1-year change 3-year change Capi.($)
+2.12%+0.89% - - 1.05TCr
+0.11%+1.71%+63.52%+117.61% 1,05500Cr
+0.27%+0.92%+51.33%+73.35% 65TCr
+0.73%+0.68%+20.70%+74.90% 47TCr
-1.36%-2.58%+40.20%+42.33% 35TCr
+1.34%+4.53%+23.37%+29.55% 27TCr
-0.48%-0.54%+13.56%+13.50% 26TCr
+0.85%+6.35%+53.17%+54.39% 22TCr
+0.85%+1.10%+35.78%+101.82% 19TCr
-0.30%-2.98%-27.62%-61.28% 17TCr
Average +0.33%+0.52%+30.45%+49.57% 40.43TCr
Weighted average by Cap. -0.05%+1.00%+40.69%+69.85%

Financials

2027 *2028 *
Net sales 35TCr 366.53Cr 322.36Cr 304.83Cr 276.49Cr 519.25Cr 522.27Cr 3.65TCr 1.41TCr 18TCr 1.38TCr 1.35TCr 58TCr 39TCr 409.15Cr 359.85Cr 340.28Cr 308.64Cr 579.63Cr 583Cr 4.07TCr 1.57TCr 20TCr 1.54TCr 1.5TCr 64TCr
Net income 3.69TCr 38Cr 34Cr 32Cr 29Cr 55Cr 55Cr 383.12Cr 147.97Cr 1.88TCr 144.45Cr 141.32Cr 6.06TCr 4.88TCr 51Cr 45Cr 42Cr 38Cr 72Cr 72Cr 506.46Cr 195.6Cr 2.49TCr 190.95Cr 186.82Cr 8.01TCr
Net Debt -3.16TCr -33Cr -29Cr -27Cr -25Cr -47Cr -47Cr -327.62Cr -126.53Cr -1.61TCr -123.52Cr -120.85Cr -5.18TCr -5.16TCr -54Cr -47Cr -45Cr -41Cr -76Cr -77Cr -535.47Cr -206.8Cr -2.63TCr -201.89Cr -197.52Cr -8.46TCr
Logo Dr. Reddy's Laboratories Limited
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Employees
27,527
Date Price Change Volume
28/26/28 $12.51 +2.12% 40,29,548
25/26/25 $12.25 -0.41% 31,68,894
24/26/24 $12.30 -0.73% 30,36,577
23/26/23 $12.39 -1.43% 24,85,104
22/26/22 $12.57 +1.37% 30,93,864
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
38
Last Close Price
1,222.50INR
Average target price
1,264.48INR
Spread / Average Target
+3.43%

Quarterly revenue - Rate of surprise